SITEMAP 창 닫기

History

  • 2019
    • 07
      Co-promotion Agreement with GSK KOREA (REQUIP, LAMICTAL, NARAMIG, IMIGRAN)
  • 2018
    • 11
      Seoul Research Institute was established
    • 10
      Product Registration and Distribution Agreement with MYLAN (CLOZARIL)
    • 09
      Export to Turkey
    • 07
      Subsidiary Company, AMBRO B&P Co., Ltd was founded
    • 06
      40th Foundation Anniversary Ceremony was held
    • 05
      Export to Yemen
    • 01
      License and Distribution Agreement with Bial (ZEBINIX)
  • 2017
    • 11
      Supply Agreement with Les Laboratories Servier (ARGOTIN)
    • 11
      Munjeong-dong building transferred (to 11 6-Gil, Beopwon-Ro, Songpa-gu)
  • 2016
    • 01
      Export to Mongolia
  • 2015
    • 09
      Distribution and Promotion Agreement with Sandoz Korea (MIRTAX)
    • 05
      Distribution and Promotion Agreement with Sandoz Korea (Fluconazole, Amlodipine)
  • 2014
    • 09
      Distribution and Promotion Agreement with Allergan Korea (BOTOX, JEVEDERM)
  • 2013
    • 09
      Products Distribution and Promotion Agreement with Abbott Korea (DEPAKOTE)
    • 07
      Distribution Agreement with Shire Ireland (METADATECD)
    • 01
      Distribution and Promotion Agreement with Sandoz Korea (Escitalopram, Sertraline and Paroxeitne)
  • 2012
    • 03
      CEO&President Wonbum Lee was appointed as the fifth head of the company
  • 2011
    • 12
      Risperidone achieved 10 billion Won annual sales
    • 04
      An agreement was made with KIOM on obesity medication technology transfer
  • 2010
    • 07
      Co-promotion & Distribution Agreement with Lundbeck Korea (Nalmefene)